###### Strengths and limitations of this study

-   First study to perform a scientometric analysis of research output from primary care databases of electronic patient records.

-   We analysed articles published from 1995 to 2015 in order to explore the historical breadth and growth of this type of research.

-   The analysis is limited to articles and structured data retrieved from the Scopus database.

-   Some latest articles and related citations might not have appeared in Scopus when the data set was extracted.

Introduction {#s1}
============

Big data (analytics) refer to the aggregation and interrogation of---high volume, high velocity, high variety---data sets so as to reveal new, non-obvious, information and patterns.[@R1] This field is advancing because of technological and scientific developments in information infrastructure and digitisation.[@R2] For governments, opening up the data sets states hold about their citizens is believed to have, through computational and algorithmic analyses, a disruptive and transformative effect on knowledge.[@R3] In the UK, big (open) data have been at the forefront of research activity and policymaking. Termed as one of the eight great technologies,[@R4] UK has embraced the big (open) data movement more than many other developed countries (eg, USA, Australia, France).[@R3] One area of particular relevance to big data analytics is healthcare.

In UK, the National Health Service (NHS) is organised around primary care and, unless there is an accident or emergency, whenever citizens would like to use the NHS they have to go through their primary care physician, known in the UK as a general practitioner (GP). From there, they can be referred to a specialist at a hospital if necessary. Secondary care clinicians can then feedback information to GPs. Since the vast majority of the population (98%) is registered with a general practice, GPs act not only as the main gatekeepers for the NHS but also as important custodians of a longitudinal electronic health record (EHR).[@R5] There are now many ongoing primary care databases of anonymised patient records in UK that can be used for healthcare research. These population-based databases contain data originating from routine general practice. Some newly established databases and research platforms of linked EHRs include ResearchOne[@R6] and CALIBER.[@R7] While there are more than 9600 general practices in UK that could potentially contribute data to these databases,[@R8] it is usually 6--10% of these practices that do so.

Such databases are usually used for cross-sectional surveys, case--control or cohort studies and for epidemiological, drug safety, clinical and healthcare usage research purposes. They rely heavily on individual general practices voluntarily contributing data via the propriety clinical systems they use to maintain these patient records. The records are usually anonymised or pseudoanonymised at source by allocating a unique number to each patient to allow for the updates of the records as well as for their linkage to other data sets, such as national mortality, national cancer registration and hospital records as well as with socioeconomic, ethnicity and environmental data sets. Access to these data sets is usually granted after scientific and ethics review and can be tailored to customer requirements. In this study, we examined the research output of three such databases that are well established in the research community and have contributed to a substantial number of scientific studies and publications. These are the Clinical Practice Research Datalink (CPRD),[@R9] The Health Improvement Network (THIN)[@R10] and QResearch.[@R11]

The CPRD (formerly known as the General Practice Research Database) is a not-for-profit research service funded by the NHS National Institute for Health Research (NIHR) and the Medicines and Healthcare products Regulatory Agency (MHRA). It is owned by the UK Department of Health and contains the records of 11 million patients (4.4 million active) from 674 general practices.[@R5] There is a service cost associated with the preparation of the requested data. Unlike the other services described below, CPRD does not extract data from a particular propriety clinical system. Any general practice can contribute data after a data sharing agreement with the software supplier. Importantly, it is the only database accessible online.[@R12] The THIN database contains the health records of 12 million patients from around 600 general practices that use the Vision clinical system by In Practice Systems (INPS). IMS Health can provide access to data, for example, via a yearly sublicense to an academic institution. THIN is the only database that can provide access to data for for-profit companies. QResearch is a research service located at the University of Nottingham. Its database contains the health records of 18 million patients from 1000 general practices that use the EMIS clinical system. Only academics employed by a UK university can have (in site) access only to a sample of the data set (maximum 100 000 patients) that is sufficient to answer a specific research question or hypothesis. As this research service is not-for-profit and entirely self-funded, there is usually a fee to be paid to cover the cost of the data extraction.

The strengths of these databases lie in their size, breadth, representativeness of the UK population, long-term follow-up and data quality.[@R5] They include good information on morbidity and lifestyle, prescribing, preventive care, current standards of care and interpractice variation.[@R13] Since they are continually (and automatically) updated, they are ideal for researchers to discover and monitor healthcare trends as well as the effectiveness of new interventions and treatments, with minimum cost. They are increasingly linked to secondary care and mortality data sets. In contrast, their weaknesses include the fact that data are extracted from propriety clinical systems developed for patient management and not for healthcare research. There are issues of missing data (eg, from healthy patients), variable definitions for diagnoses and incomplete secondary care data (eg, hospital admissions). Wider health data (eg, treatment adherence, over the counter medication) and data about subpopulations (eg, prisoners, homeless people, refugees, travellers) are not captured adequately.[@R5] Information governance and informed consent procedures around the data sharing of EHRs for research are still considered complex.[@R14] These databases also require considerable clinical and scientific expertise, as well as technical capacity in data management to support research. When selecting a particular data resource for an observational study, researchers have to consider several other factors, such as the population covered and its geographical distribution, data capture and latency, linkage with other resources, privacy and security, quality and validation.[@R15]

Nonetheless, these databases are highly regarded within the research community since they have proved their value in helping researchers reach definitive answers in various healthcare debates of considerable public interest, particularly where other types of research have produced contradictory evidence. For example, in 2004 researchers from UK and Canada proved beyond doubt that measles--mumps--rubella (MMR) vaccination is not associated with autism in children.[@R16] In contrast to expensive, time-consuming, and unrepresentative (of the population) traditional randomised trials,[@R17] large-scale and randomised observational (comparative) evaluations of treatments and medications are minimally obtrusive for clinicians and patients and can support faster turnaround times for pragmatic evidence useful in clinical practice.[@R18]

The aim of this study was to perform a scientometric analysis of articles, published from 1995 to 2015, which have used data from at least one of these primary care databases. This empirical, semiautomated, method of quantitatively analysing a large number of publications provides a reliable and objective examination of the current status and trends as well as the structure and dynamics of this scientific field.[@R19] [@R20] In this way, policymakers, research funding bodies but most importantly new researchers entering this field can have a general overview of its knowledge base and an indication of what kind of network features, research activities and topics of interest are driving it.[@R20] [@R21] To the best of our knowledge, this is the first study of a systematic mapping of primary care databases research output.

Methods {#s2}
=======

In this study, Elsevier\'s Scopus database (<http://www.scopus.com>) was selected as the source of structured data on articles. This database covers more scientific articles than other databases (eg, Thomson Reuters Web of Science) and has the advantage of providing advance export functionality of structured data, including full citation information, abstracts, keywords and references. On 30 October 2015, we searched, using the document search functionality, for all articles containing the terms 'General Practice Research Database (GPRD)' OR 'Clinical Practice Research Datalink (CPRD)' OR 'The Health Improvement Network (THIN)' OR 'QResearch' in article title, abstract and keywords.

The results were then limited to *articles*, *articles in press*, *conference papers*, *reviews*, *book chapters* and *short surveys. Notes*, *letters*, *editorials* and *errata* were excluded from the analysis. From there, we compared the resulted records with the bibliographic lists maintained by these databases[@R22] so as to include articles that could not be retrieved using the above search queries. Data cleansing included the removal of duplicate records and records that were missing essential information for the analysis (eg, article title, journal). The fields of *authors*, *year*, *source title*, *affiliations*, *author keywords* and *document type* were used for the analysis.

The final bibliography retrieved from Scopus was imported to [Table 2](#BMJOPEN2016012785TB2){ref-type="table"} Net[@R25] to extract networks of authors and contributing countries. It was then imported to Gephi[@R26] where the ForceAtlas 2 algorithm[@R27] was used to visualise the structural proximities for the communities of authors and contributing countries. The VOSviewer (V.1.6.3)[@R28] software was used to visualise bibliometric networks and densities[@R29] of frequent terms and journals. All other statistical analyses were performed using Microsoft Excel. We used the Journal Citation Reports (JCR) Science Edition 2014 to extract impact factor values for the identified journal titles.

Results {#s3}
=======

A total of 1891 papers from 1995 to 2015 were included in this bibliometric and scientometric analysis. The results are presented below.

Publication and citation trends {#s3a}
-------------------------------

The literature related to the 3 primary care databases in England increased gradually from 7 papers in 1995 to 171 in 2015 ([table 1](#BMJOPEN2016012785TB1){ref-type="table"}). We estimated their compound annual growth rate (CAGR), for the years 1995--2014, to be 18.65%. The vast majority of papers were published in English across 425 different sources (16.76% CAGR for 1995--2014). In total, these papers have already been cited 73 929 times. There is, however, a small percentage of 1.16% (n=163) papers that have not yet been cited yet. The average citation per year is ∼3.52.

###### 

Distribution of scientific literature by year

  Year    No. of papers   Per cent   No. of citations   No. of different sources
  ------- --------------- ---------- ------------------ --------------------------
  2015    171             9.04       255                107
  2014    214             11.31      1188               114
  2013    203             10.73      1934               123
  2012    175             9.25       3050               99
  2011    148             7.82       3900               100
  2010    129             6.82       5232               81
  2009    126             6.66       5341               79
  2008    115             6.08       4757               73
  2007    96              5.07       5232               65
  2006    74              3.91       5943               56
  2005    81              4.28       5839               56
  2004    73              3.86       6411               49
  2003    46              2.43       2998               37
  2002    52              2.74       3832               37
  2001    51              2.69       3770               38
  2000    51              2.69       6334               35
  1999    26              1.37       1594               21
  1998    29              1.53       2582               20
  1997    17              0.89       1560               13
  1996    7               0.37       1137               7
  1995    7               0.37       1040               6
  Total   1891            100        73 929             425

We explored the distribution of publications by document type. This is presented in [table 2](#BMJOPEN2016012785TB2){ref-type="table"} to identify the preferences of scholars using these databases in their research to share knowledge. The vast majority of scholars prefer to publish the findings of their research through journals, particularly as original articles (96.5%).

###### 

Distribution of scientific literature by document type

  Type               No. of papers   Per cent
  ------------------ --------------- ----------
  Article            1825            96.5
  Conference paper   18              0.95
  Book chapter       4               0.21
  Review             41              2.16
  Short survey       3               0.15

Next, we analysed the distribution of papers based on the academic discipline in which they have been categorised by Scopus ([table 3](#BMJOPEN2016012785TB3){ref-type="table"}) and by which each paper may be attributed to more than one subject area.[@R30] Since we analysed bibliographic data based on published research using primary care databases, it comes as no surprise that the vast majority of papers are under the *medicine* category. There is, however, a considerable number of papers (∼25%) under the categories *biochemistry, genetics and molecular biology* and *pharmacology, toxicology and pharmaceutics*, which indicates an emphasis on the use of these databases for the study of medications. It also indicates the potential interest in these databases from the pharmaceutical sector.

###### 

Distribution of scientific literature by discipline

  Subject                                        No. of papers   Per cent
  ---------------------------------------------- --------------- ----------
  Medicine                                       1838            97.2
  Biochemistry, genetics and molecular biology   266             14.1
  Pharmacology, toxicology and pharmaceutics     197             10.4
  Neuroscience                                   78              4.1
  Immunology and microbiology                    70              3.7
  Agricultural and biological sciences           53              2.8
  Nursing                                        44              2.3
  Psychology                                     21              1.1
  Arts and humanities                            13              0.7
  Environmental science                          10              0.5

Most productive institutions and countries {#s3b}
------------------------------------------

For a deeper insight into contribution patterns and scientific impact, we first identified the top 10 institutions (by number of papers) authors have used as affiliation and then we analysed citation patterns ([table 4](#BMJOPEN2016012785TB4){ref-type="table"}). We also analysed authors\' affiliations based on the country of their institution. For this, each publication was assigned to its authors\' respective affiliated countries so as to identify the network of multinational collaborations. The distribution of the top 10 contributing countries is presented in [table 5](#BMJOPEN2016012785TB5){ref-type="table"}. Finally, we visualised the network of contributing countries using Gephi. We ended up with a network of 29 nodes and 175 edges ([figure 1](#BMJOPEN2016012785F1){ref-type="fig"}). Each node represents a country, while its size denotes the country\'s degree and the colour the number of papers. The thickness of interconnected lines (edges) denotes the number of coauthored papers between the countries.

###### 

Most productive institutions

  Rank   Institution                                                     No. of papers   Per cent   Total citations   Median (IQR)       Country
  ------ --------------------------------------------------------------- --------------- ---------- ----------------- ------------------ -----------------
  1      University of Nottingham                                        266             14.06      11 540            18 (6--44.75)      UK
  2      Boston University                                               228             12.05      12 328            21.5 (6--57)       USA
  3      Centro Espanol de Investigacion Farmacoepidemiologica (CEIFE)   163             8.62       8493              26 (7--59.5)       Spain
  4      University College London                                       156             8.25       5226              14 (4.75--37)      UK
  5      London School of Hygiene & Tropical Medicine                    124             6.55       3696              14 (4--40.5)       UK
  6      University of Utrecht                                           118             6.24       5067              17.5 (4--48.75)    The Netherlands
  7      University of Pennsylvania                                      110             5.81       7508              24.5 (10--64.25)   USA
  8      Medicines and Healthcare Products Regulatory Agency             94              4.97       2623              14 (4--33.25)      UK
  9      King\'s College London                                          92              4.86       2221              13 (4--32.75)      UK
  10     University of Oxford                                            86              4.54       1806              9.5 (3--23.25)     UK

###### 

Top contributing countries

  Rank   Country       No. of papers   Per cent
  ------ ------------- --------------- ----------
  1      UK            1202            63.56
  2      USA           563             29.77
  3      Spain         192             10.15
  4      Netherlands   164             8.67
  5      Switzerland   115             6.08
  6      Canada        112             5.92
  7      Sweden        106             5.60
  8      Germany       64              3.38
  9      France        51              2.69
  10     Italy         36              1.90

![Network of contributing countries.](bmjopen2016012785f01){#BMJOPEN2016012785F1}

The majority of the most productive institutions are universities. Top universities include the University of Nottingham, Boston University, University College London (UCL), the London School of Hygiene & Tropical Medicine and the University of Utrecht. Apart from these academic institutions, a research unit in Spain (CEIFE) and the MHRA in the UK are involved in primary care databases-based research. In this table, we also report the medians along with the IQRs. From this, it seems that scholars from CEIFE, University of Pennsylvania and Boston University are coauthors in publications that are highly cited compared to the other institutions in this list. Switzerland, Canada, Sweden, Germany, France and Italy had no institution among the top 10 list, although they were ranked among the top 10 productive countries. Most papers are published by scholars from UK (63.56%), followed by the USA and Spain. With the exception of USA and Canada, most of the productive countries are in Europe. What is particularly interesting in these two tables is that scholars in institutions from the USA and Spain produce not only a great number of publications but also publications that are widely recognised by this scientific community in terms of citations.

Taking into account the measurements of *weighted degree*, *clustering*, *eigenvector centrality* and *betweenness centrality* ([table 6](#BMJOPEN2016012785TB6){ref-type="table"}), we observe that once again the UK, followed by USA, is placed at the centre of this scientific community. With the highest degrees of all measurements, institutions from this country are the most well-connected and authoritative ones, facilitating the linking between institutions in other countries.

###### 

Top countries by centrality

  Rank   Country       Occurrences   Weighted degree   Page rank   Eigen centrality   Closeness centrality   Betweenness centrality
  ------ ------------- ------------- ----------------- ----------- ------------------ ---------------------- ------------------------
  1      UK            5770          27.0              0.062       1.0                0.933                  0.250
  2      USA           2506          26.0              0.060       0.98               0.903                  0.229
  3      Netherlands   666           22.0              0.047       0.95               0.8                    0.049
  4      Canada        567           18.0              0.039       0.83               0.717                  0.024
  5      Switzerland   409           18.0              0.039       0.85               0.717                  0.015
  6      Italy         85            17.0              0.037       0.78               0.7                    0.024
  7      Spain         481           17.0              0.037       0.82               0.7                    0.011
  8      Australia     37            16.0              0.036       0.76               0.682                  0.024
  9      Sweden        315           16.0              0.036       0.77               0.682                  0.023
  10     Germany       121           16.0              0.036       0.71               0.682                  0.020

Top journals {#s3c}
------------

In [table 7](#BMJOPEN2016012785TB7){ref-type="table"}, we identify the top 10 journals where most research is published. Six of these journals are published by a UK publisher, and the rest are published in the USA. The journal *Pharmacoepidemiology and Drug Safety* features at the top of list, followed by the *British Journal of Clinical Pharmacology* and *Pharmacotherapy*, which signifies the focus of research, produced from these primary care databases, on the safe use of medication. This focus can also be seen in [table 3](#BMJOPEN2016012785TB3){ref-type="table"}, where (apart from medicine) most papers are published in the fields of *biochemistry, genetics and molecular biology* and *pharmacology, toxicology and pharmaceutics* (Scopus classification), but also in [table 5](#BMJOPEN2016012785TB5){ref-type="table"}, where most of the top-cited papers refer to potential risk for particular complications/conditions from the use of specific medication. More specialised journals, such as *Diabetes Care* and *Annals of the Rheumatic Diseases*, are also featured in this list, indicating a particular focus of research activity in specific spectrums of diseases.

###### 

Top journals of published research

  Rank   Journal name                                 No. of papers   Per cent   Publisher                                Impact factor   Open access   Country
  ------ -------------------------------------------- --------------- ---------- ---------------------------------------- --------------- ------------- ---------
  1      *Pharmacoepidemiology and Drug Safety*       115             6.08       Wiley                                    2.939           Hybrid        UK
  2      *British Medical Journal*                    100             5.28       BMJ Publishing Group                     17.445          Full          UK
  3      *British Journal of General Practice*        67              3.54       Royal College of General Practitioners   2.294           Full          UK
  4      *British Journal of Clinical Pharmacology*   57              3.01       Wiley                                    3.878           Hybrid        UK
  5      *PLoS One*                                   51              2.69       Public Library of Science                3.234           Full          USA
  6      *BMJ Open*                                   41              2.16       BMJ Publishing Group                     2.271           Full          UK
  7      *Pharmacotherapy*                            34              1.79       Wiley                                    2.662           Hybrid        USA
  8      *Diabetes Care*                              30              1.58       American Diabetes Association            8.420           Hybrid        USA
  9      *Epidemiology*                               24              1.26       Wolters Kluwer                           6.196           Hybrid        USA
  10     *Annals of the Rheumatic Diseases*           23              1.21       BMJ Publishing Group                     10.377          Hybrid        UK

Four journals in this list are open access (*BMJ*, *British Journal of General Practice*, *PLoS One*, *BMJ Open*), which greatly facilitates the sharing of knowledge without limitations. The *BMJ* enjoys widespread recognition of the high quality of its published studies, as indicated by the high impact factor. The rest are behind a pay wall but offer authors an open access option to publish their research (hybrid access). An extra column with the Impact Factors of these top 10 journals from the 2014 JCR was also added in the table.

What is also of particular importance in terms of scientific impact is that the 10 most cited papers identified (see [table 8](#BMJOPEN2016012785TB8){ref-type="table"}) have not been published in journals in this list. However, by performing a (full counting) analysis of cocitation links in VOSviewer ([figure 2](#BMJOPEN2016012785F2){ref-type="fig"}) for journals cited in the Scopus data set (minimum number of citations=10) we see that most of this list is represented here (blue---lowest density, red---highest density).

###### 

Most cited papers

  Rank                                                                                                                                                    Authors/title                                                                                                                     Year   Country                                  Journal                                            Impact factor   Citations   Open access
  ------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------- ------ ---------------------------------------- -------------------------------------------------- --------------- ----------- -------------
  1                                                                                                                                                       Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA                                                                             2000   USA                                      *Lancet*                                           45.217          1322        No
  Statins and the risk of dementia                                                                                                                                                                                                                                                                                                                                                                                         
  2                                                                                                                                                       Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB                                                                   2006   USA                                      *Journal of the American Medical Association*      35.289          854         Yes
  Risk of myocardial infarction in patients with psoriasis                                                                                                                                                                                                                                                                                                                                                                 
  3                                                                                                                                                       Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C                                                                          2000   UK                                       *Journal of Bone and Mineral Research*             6.832           796         Yes
  Use of oral corticosteroids and risk of fractures                                                                                                                                                                                                                                                                                                                                                                        
  4                                                                                                                                                       Henry D, Lim LLY, Rodriguez LAG, Perez Gutthann S, Carson JL, Griffin M, Savage R Logan R, Moride Y, Hawkey C, Hill S, Fries JT   1996   Australia, Spain, USA, New Zealand, UK   *British Medical Journal*                          17.445          688         Yes
  Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis                                                                                                                                                                                                                                                                    
  5                                                                                                                                                       Yang YX, Lewis JD, Epstein S, Metz DC                                                                                             2006   USA                                      *Journal of the American Medical Association*      35.289          637         Yes
  Long-term proton pump inhibitor therapy and risk of hip fracture                                                                                                                                                                                                                                                                                                                                                         
  6                                                                                                                                                       Currie CJ, Poole CD, Gale EAM                                                                                                     2009   UK                                       *Diabetologia*                                     6.671           629         Yes
  The influence of glucose-lowering therapies on cancer risk in type 2 diabetes                                                                                                                                                                                                                                                                                                                                            
  7                                                                                                                                                       Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C                                                                                1995   USA, UK                                  *Lancet*                                           45.217          612         No
  Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components                                                                                                                                                                                                                                                                     
  8                                                                                                                                                       Dial S, Delaney JAC, Barkun AN, Suissa S                                                                                          2005   Canada                                   *Journal of the American Medical Association*      35.289          582         Yes
  Use of gastric acid-suppressive agents and the risk of community-acquired *Clostridium difficile*-associated disease                                                                                                                                                                                                                                                                                                     
  9                                                                                                                                                       Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P                                                                 2004   UK                                       *New England Journal of Medicine*                  55.873          546         Yes
  Risk of myocardial infarction and stroke after acute infection or vaccination                                                                                                                                                                                                                                                                                                                                            
  10                                                                                                                                                      Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM                                                                   2006   USA                                      *Journal of the American Academy of Dermatology*   4.449           528         No
  Prevalence of cardiovascular risk factors in patients with psoriasis                                                                                                                                                                                                                                                                                                                                                     

![Journal cocitation analysis.](bmjopen2016012785f02){#BMJOPEN2016012785F2}

Most cited papers {#s3d}
-----------------

Next, we focused on the top 10 papers[@R31] and calculated the total count of citations for each paper ([table 8](#BMJOPEN2016012785TB8){ref-type="table"}) for the period 1995--2015. Citations totalled 7194 (1.02%) of all citations in this data set. It seems that these studies in dementia, psoriasis, fractures, cardiovascular diseases and gastrointestinal complications in relation to certain medications have been of great interest in this scientific community. The majority of the top 10 most cited papers (60%) are open access at the publisher\'s website and can be freely read by anyone.

Of the 10 papers, 8 are single country papers, while none were singled authored. Again, the USA has a considerable presence in this list, producing papers that are highly cited. In addition, many of the highly productive authors identified ([table 10](#BMJOPEN2016012785TB10){ref-type="table"}) were also found in this list.

Authorship patterns and networks {#s3e}
--------------------------------

Authorship distributions varied from single to a maximum of 155 authors---for a study about the feasibility of international collaboration to evaluate, based on a common protocol, the risk of Guillain--Barré syndrome following pH1N1 vaccination.[@R41] In total, there were 9385 authors involved in the 1981 papers during 1995--2015. In [table 9](#BMJOPEN2016012785TB9){ref-type="table"}, we can see that more than three-quarters of all papers were published by three or more authors. Only 1% of papers were written by a single author, while five papers did not have any authorship details. Almost a quarter of all papers was published by four authors, which have been widely cited across this scientific community. This indicates the high degree of expert collaboration in this field, that is necessary in analysing millions of primary care records.

###### 

Coauthorship distribution

  Rank   No. of authors   No. of papers   Per cent   Citations   Per cent
  ------ ---------------- --------------- ---------- ----------- ----------
  1      4                460             24.33      16 437      22.23
  2      5                383             20.25      16 071      21.74
  3      3                310             16.39      12 209      16.51
  4      6                252             13.33      12 084      16.35
  5      2                145             7.67       7159        9.68
  6      7                123             6.50       3798        5.14
  7      8                88              4.65       2914        3.94
  8      \>11             48              2.54       1792        2.42
  9      9                28              1.48       617         0.83
  10     10               25              1.32       412         0.56
  11     1                19              1.00       436         0.59

[Table 10](#BMJOPEN2016012785TB10){ref-type="table"} provides the ranking of the top 10 scholars, first, in terms of research productivity based on the overall number of coauthored papers. While, generally, most scholars are from the UK, the Director of the Spanish Centre for Pharmacoepidemiologic Research (CEIFE)[@R42] is the scholar with the most published research from these primary care databases. Also, there are researchers in this field who do not necessarily come from the academic environment. The pharmaceutical sector is actively involved in knowledge production from electronic primary care records.

###### 

Most productive authors

  Rank     Author                     Affiliation                                                 Country       No. of papers   Weighted degree   Clustering   Eigen centrality   Closeness centrality   Betweenness centrality
  -------- -------------------------- ----------------------------------------------------------- ------------- --------------- ----------------- ------------ ------------------ ---------------------- ------------------------
  1        Rodriguez LAG              Spanish Centre for Pharmacoepidemiologic Research (CEIFE)   Spain         166             82.0              0.082        0.346              0.337                  0.073
  2        Jick SS                    Boston University                                           USA           142             90.0              0.066        0.327              0.329                  0.078
  3        Van Staa TP                University of Manchester                                    UK            115             144.0             0.063        1.0                0.403                  0.217
  4        Jick H                     Boston University                                           USA           98              55.0              0.098        0.217              0.322                  0.032
  5        Meier CR                   University of Basel                                         Switzerland   94              54.0              0.116        0.232              0.294                  0.014
  6        Hubbard R                  University of Nottingham                                    UK            86              82.0              0.092        0.441              0.359                  0.067
  7        Smeeth L                   London School of Hygiene & Tropical Medicine                UK            79              89.0              0.101        0.578              0.366                  0.067
  8        Hippisley-Cox J            University of Nottingham                                    UK            72              57.0              0.144        0.244              0.325                  0.065
  9        Johansson S                AstraZeneca                                                 Sweden        70              46.0              0.218        0.267              0.310                  0.012
  10       Cooper C                   University of Southampton                                   UK            65              67.0              0.139        0.414              0.342                  0.035
  West J   University of Nottingham   UK                                                          65            42.0            0.213             0.230        0.310              0.012                  

Considering only those scholars who have coauthored at least two papers in this data set, the analysis suggested a network ([figure 3](#BMJOPEN2016012785F3){ref-type="fig"}) with 1261 nodes and 6186 edges. Here, each node represents an author, while its size denotes the number of author\'s papers. The interconnected lines (edges) denote the coauthored papers between those authors. For better visualisation, we limited the number of minimum degrees to 5 (maximum degrees=145). After a modularity measurement, to identify community structure,[@R43] we observe some established collaborative teams (clusters with different colours) around specific and highly productive scholars in the analysis of data from primary care databases also found in [table 10](#BMJOPEN2016012785TB10){ref-type="table"}. We also observe a new (blue) cluster around the lead statistician for THIN[@R44]---one of the three primary care databases studied.

![Clustered coauthor network.](bmjopen2016012785f03){#BMJOPEN2016012785F3}

Taking into account the measurements of *weighted degree*, *clustering*, *eigenvector centrality* and *betweenness centrality* ([table 10](#BMJOPEN2016012785TB10){ref-type="table"}), results indicate a cluster placed at the centre of this scientific community. With the lowest degree of clustering and the highest degrees of all the other measurements, its prominent scholar is the most well-connected, facilitating, more than any other scholar, linking between other scientific clusters and scholars.

What is also particularly interesting is the fact that some of the scholars (and their institutions) in this list are affiliated, to a certain extent, to these databases, having served or currently acting as their founders, directors, lead scientists or members of their scientific committee.[@R45] [@R46] For example, lead scientists from the Boston Collaborative Drug Surveillance Program in Boston University were among the first who developed the technical and scientific capacity of these databases in pharmacoepidemiological research.[@R47] [@R48]

Research topics {#s3f}
---------------

We conducted a keyword analysis to identify important topics of published research. For this, we first extracted from the bibliographic data set 5813 unique keywords as indexed by Scopus[@R30] to base our analysis on more complete indexing information compared to authors\' keywords. We retrieved the top 30 keywords for two specific categories: *medical conditions* and *medications/substances* ([tables 11](#BMJOPEN2016012785TB11){ref-type="table"} and [12](#BMJOPEN2016012785TB12){ref-type="table"}). Next, we created a (full counting of) term co-occurrence density map in VOSviewer ([figure 4](#BMJOPEN2016012785F4){ref-type="fig"}) by building a text corpus out of the title and abstract fields in the bibliographic data set (minimum number of a term occurrence=10). In this way, we were able to identify topics that not only appear more frequently in the literature, but that were also strongly related to each other, forming clusters of topics. Blue indicates a low density of terms and red indicates the highest density of terms. In many cases, the density map represents the frequency of indexed keywords in [tables 11](#BMJOPEN2016012785TB11){ref-type="table"} and [12](#BMJOPEN2016012785TB12){ref-type="table"}. Clearly, smoking, diabetes, cardiovascular diseases, mental illnesses, psoriasis, obesity, pregnancy and cancer as well as medication and substances that can treat these medical conditions, such as aspirin, insulin, antidepressants and non-steroid anti-inflammatory agents (NSAIDs), have been of great interest for scholars using EHRs in primary care.

###### 

Top keywords: medical conditions

  Rank   Keyword                                   Occurrences   Rank   Keyword                            Occurrences
  ------ ----------------------------------------- ------------- ------ ---------------------------------- -------------
  1      Smoking                                   328           16     Cardiovascular diseases            96
  2      Diabetes mellitus                         223           17     Myocardial infarction              94
  3      Hypertension                              223           18     Chronic obstructive lung disease   90
  4      Non-insulin dependent diabetes mellitus   179           19     Heart failure                      86
  5      Depression                                167           20     Cerebrovascular accident           85
  6      Stroke                                    165           21     Rheumatoid arthritis               83
  7      Asthma                                    158           22     Epilepsy                           81
  8      Diabetes mellitus, type 2                 155           23     Breast cancer                      78
  9      Cancer risk                               150           24     Fracture                           75
  10     Cardiovascular risk                       147           25     Psoriasis                          75
  11     Cardiovascular disease                    133           26     Gastrointestinal haemorrhage       69
  12     Obesity                                   129           27     Hip fracture                       68
  13     Heart infarction                          126           28     Osteoporosis                       68
  14     Pregnancy                                 125           29     Colorectal cancer                  65
  15     Ischaemic heart disease                   104           30     Fractures, bone                    65

###### 

Top keywords: medications/substances

  Rank   Keyword                                                Occurrences   Rank   Keyword                                          Occurrences
  ------ ------------------------------------------------------ ------------- ------ ------------------------------------------------ -------------
  1      Non-steroid anti-inflammatory agent                    182           16     Proton pump inhibitor                            75
  2      Acetylsalicylic acid                                   154           17     Warfarin                                         71
  3      Metformin                                              150           18     Antidiabetic agent                               69
  4      Corticosteroid                                         143           19     Anticonvulsive agent                             68
  5      Hydroxymethylglutaryl coenzyme a reductase inhibitor   138           20     Serotonin uptake inhibitor                       65
  6      Insulin                                                133           21     Calcium channel blocking agent                   64
  7      Antidepressant agent                                   124           22     Antibacterial agents                             62
  8      β adrenergic receptor blocking agent                   108           23     Hydroxymethylglutaryl-coA reductase inhibitors   62
  9      Hypoglycemic agents                                    91            24     Oral antidiabetic agent                          61
  10     Anti-inflammatory agents, non-steroidal                90            25     Paracetamol                                      56
  11     Dipeptidyl carboxypeptidase inhibitor                  88            26     Diuretic agent                                   53
  12     Antihypertensive agent                                 82            27     Ibuprofen                                        52
  13     Neuroleptic agent                                      80            28     Simvastatin                                      52
  14     Antibiotic agent                                       77            29     Tricyclic antidepressant agent                   52
  15     Hemoglobin A1c                                         75            30     Diclofenac                                       50

![Term co-occurrence density map.](bmjopen2016012785f04){#BMJOPEN2016012785F4}

Discussion {#s4}
==========

This study identified the leading institutions, countries, authors, journals and topics as well as their networks of published research that have used primary care databases in the UK to extract and analyse data from EHRs. There is a growing production of such papers which indicates the interest of a global and highly collaborative scientific community in this field and also the knowledge and insights that can be gained for healthcare improvement. Publication output increased from 7 papers in 1995 to 171 by October 2015 (18.65% CAGR for 1995--2014). It may be worth noting that by performing a similar, limited to the UK, search in Scopus for the same period and with the keyword 'primary care' we found a 10.83% CAGR, which shows the increase in research conducted from these databases outstrips the field more generally. The vast majority of publications (96.5%) were journal articles. While this research field can be located, generally, in medicine, biochemical and pharmaceutical developments seem to be equally important, aimed at addressing widespread medical conditions, such as diabetes, cardiovascular diseases, mental illnesses, smoking, obesity and cancer.

The UK has been well placed in this scientific field. This is partly due to the fact that there is now more than 30 years of data available in GP information systems.[@R49] The investment in developing primary care databases from EHRs for research purposes has placed the country at the centre of a network of collaborations across the globe, bringing together international expertise for the analysis of ever-expanding and increasingly interlinked clinical data sets from primary, secondary and tertiary care. Access to these data sets has also allowed researchers and institutions from other countries to develop their own programmes of research to answer important clinical questions. Six of the most productive institutions are located in the UK, and 63.56% of publications were authored by scholars affiliated with this country, followed by the USA. Interestingly, the top institutions were not exclusively universities. Among them, we can find a research unit in Spain (CEIFE) and the executive agency in UK that funds and runs the CPRD database (MHRA), while one of the most productive scholars is affiliated with a pharmaceutical company. This signifies the great interest of various actors, from academic, governmental and private sectors, in research with primary care databases.

The geographical trend can also be observed from the location of journals with the most published papers. Six of the top 10 journals are published in the UK, followed by the USA. The journals with the most papers published included *Pharmacoepidemiology and Drug Safety*, *BMJ*, *British Journal of General Practice* and *British Journal of Clinical Pharmacology*, which signifies the great interest of scholars in using data from EHRs for pharmaceutical research. This is partially because one of the oldest sets of routine information collected by GP practices in the UK and made available by these databases is drug histories.[@R47] Regarding restrictions on access to research outputs, only four journals in this list are fully open access. This may limit access to knowledge to researchers and members of the public that cannot afford subscription costs. Interestingly, it is the more established journals in medicine, such as *JAMA*, *Lancet* and *NEJM*, that have published some of the most cited papers in this bibliometric data set and enjoy a high level of cocitation activity.

Keyword analyses show that smoking, diabetes, cardiovascular diseases, mental illnesses, psoriasis, obesity, pregnancy and cancer constitute the main topics of research activity using EHRs in primary care. Often, this research concentrates on developing algorithms to identify risk of occurrence of a particular disease. Researchers are also interested in investigating medications that can treat these medical conditions, such as aspirin, other NSAIDs, insulin and antidepressants.

For the vast majority of publications, authorship varied between three and six authors, indicating widely collaborative, international, efforts to promote research in this field. Coauthorship network analyses showed that the lead scientists, directors and founders of these databases were found, to various degrees, at the centre of clusters in this scientific community, highlighting their invaluable contribution to knowledge production. As Azoulay *et al*[@R50] have demonstrated in their study about eminent researchers and the vitality of a field, the development of coauthorship networks and clusters of collaborators in newly established scientific domains might be useful to boost research productivity. On the basis of each database\'s data access requirements, their established researchers appear to have a fundamental role in facilitating and promoting international collaborations for more researchers, institutions and countries. Importantly, they have a clear and in-depth understanding of the kind of research activities these databases can support in terms of data quality, structure and EHR coding practices. As these databases are expected to open up in the future to more stakeholders from various disciplines around health and as universities prepare to incorporate training in data science skills (eg, statistics, biomedical informatics, biology and medicine)[@R51] into their clinical curricula, so as to nurture the next generation of clinical investigators,[@R52] these established researchers could promote quality, reliable and ethically appropriate scientific research[@R53] from complicated and highly contextual data sets.

Our study has the typical limitations of a scientometric study. We analysed articles published in a period of 20 years in order to explore the historical breadth and growth of research from electronic primary care records. However, this analysis is limited on structured data retrieved from one bibliometric database of peer-reviewed literature. Therefore, only articles published in journals in its index were analysed. Also, some of the latest articles and related citations might not have been retrieved at the time of the search, which might explain the decrease in the number of publications and citations particularly from 2010 onwards. It was beyond the scope of this quantitative study to assess the scientific quality and the socioeconomic impact of the large number of publications analysed here. These studies have deployed a range of study designs across many subfields of primary care research and with various research findings. Our main objective was restricted to assessing one aspect of academic impact and research quality, that is, patterns and trends in research outputs.[@R54] Future research could focus on the wider academic and socioeconomic impact of these studies by examining the relationship between publications, citation patterns and collaborations with the development of new scientific methods in the field or of new medical products and healthcare services.

In conclusion, output of primary care research from EHRs has consistently increased since their development. The development of these databases in the UK has placed the country and affiliated academic institutions at the centre of an expanding global scientific community, facilitating international collaborations and bringing together international expertise in medicine, biochemical and pharmaceutical research.
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